Please assess the completion status of the following clinical trial:

Trial Title: Reversing the Effects of 2% Lidocaine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Students of the Dalhousie University Dental Clinic who are:~* Age 18 and over~* Capable of providing informed consent~Exclusion Criteria:~* Subjects with a medical history that contraindicates the use of epinephrine.~* Subjects who have taken an opioid or an opioid-like analgesic within 24 hours of the anesthesia session.~* Pregnant females

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Phentolamine mesylate (Type: EXPERIMENTAL): Once anesthesia is confirmed, subjects in the Phentolamine mesylate group will receive 1 injection of 1ml of a solution containing 0.24 mg of phentolamine mesylate in the same site that was previously anaesthetized (not as a part of the study).
- Water (Type: PLACEBO_COMPARATOR): Once anaesthesia is confined, the subjects in the water group will receive 1 injection of 1 ml of sterile physiological water in the same site that was previously anaesthetized (not as a part of the study).

Based on this trial design, predict the completion outcome and termination type (if applicable).